Killing the Golden Goose or Just Chasing it around the Farmyard? : Rising Generic Entry and the Incentives for Early-stage Pharmaceutical Innovation
| Is generic entry reducing the flow of early-stage pharmaceutical innovation and therefore future availability of new medicines? We explore this question using novel data sources and an empirical framework that models the flow of early-stage pharmaceutical innovations as a function of generic penetration, scientific opportunity and challenges, firm innovative capability, and additional controls. |
Project Team
Chirantan Chatterjee, Lee Branstetter, and Matthew J Higgins
Sponsor
NSF SCISIP
Select Project Type
Ongoing Projects
Project Status
Ongoing (Initiated in 2011)
Funded Projects Functional Area
Strategy
Killing the Golden Goose or Just Chasing it around the Farmyard? : Rising Generic Entry and the Incentives for Early-stage Pharmaceutical Innovation
| Project Team: | Chirantan Chatterjee, Lee Branstetter, and Matthew J Higgins | |
| Sponsor: | NSF SCISIP | |
| Project Status: | Ongoing (Initiated in 2011) | |
| Area: | Strategy | |
| Abstract: |
|